Cargando…

Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers: A Case Series

BACKGROUND: The cumulative lifetime risk of ovarian cancer is 16–68% and 11–30% in female BRCA1 and BRCA2 gene alteration carriers, respectively. Risk-reducing bilateral salpingo-oophorectomy (RRSO) is the only proven way to reduce ovarian cancer mortality. We report a series of patients who underwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Barker, Victoria E., Vlachodimitropoulou, Evangelia, O’Brien, Patrick, Iskaros, Joseph, Rosenthal, Adam N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642698/
https://www.ncbi.nlm.nih.gov/pubmed/37917945
http://dx.doi.org/10.1097/AOG.0000000000005423
_version_ 1785147005699358720
author Barker, Victoria E.
Vlachodimitropoulou, Evangelia
O’Brien, Patrick
Iskaros, Joseph
Rosenthal, Adam N.
author_facet Barker, Victoria E.
Vlachodimitropoulou, Evangelia
O’Brien, Patrick
Iskaros, Joseph
Rosenthal, Adam N.
author_sort Barker, Victoria E.
collection PubMed
description BACKGROUND: The cumulative lifetime risk of ovarian cancer is 16–68% and 11–30% in female BRCA1 and BRCA2 gene alteration carriers, respectively. Risk-reducing bilateral salpingo-oophorectomy (RRSO) is the only proven way to reduce ovarian cancer mortality. We report a series of patients who underwent risk-reducing surgery at the time of planned obstetric-indicated cesarean delivery. CASES: This is a case series of four women carrying a pathogenic germline BRCA1 or BRCA2 gene alteration who underwent RRSO at the time of cesarean delivery between March 1, 2018, and March 31, 2022. All women were referred during pregnancy to the University College London Hospitals Familial Cancer Clinic for consideration of RRSO at the time of obstetric-indicated cesarean delivery. Women were considered eligible for RRSO if they had a proven pathogenic germline alteration, would have completed childbearing after the cesarean delivery, and were older than age 35 or 40 years with BRCA1 or BRCA2 alterations, respectively. Operating time, blood loss, transfusion requirements, length of hospital stay, complications, and ability to breastfeed were assessed and, where possible, compared with the institutional means for similar patients who underwent cesarean delivery only, to determine whether RRSO was associated with increased morbidity. Women were contacted 11–59 months postprocedure to assess satisfaction. The mean blood loss was 687 mL (range 400–1,000 mL), mean operating time was 68 minutes, mean length of hospital stay was 3 days, and mean change in hemoglobin was −1 g/dL. No patient required a transfusion, had internal organ damage, returned to the operating room, or was readmitted. One of two women with intact breast tissue successfully breastfed, and the other chose to bottle feed. The mean contemporaneous institutional blood loss for cesarean delivery was not significantly different at 681 mL for singleton pregnancies and 872 mL for twin pregnancies. All four women reported a high level of satisfaction with the combined procedure. CONCLUSION: Our results show that RRSO can be performed at the time of cesarean delivery with high patient satisfaction. This approach can be offered to appropriately counseled individuals, with the benefit of avoiding the need for two separate procedures, with potentially reduced patient morbidity and health care costs.
format Online
Article
Text
id pubmed-10642698
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106426982023-11-15 Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers: A Case Series Barker, Victoria E. Vlachodimitropoulou, Evangelia O’Brien, Patrick Iskaros, Joseph Rosenthal, Adam N. Obstet Gynecol Clinical Cases and Practice BACKGROUND: The cumulative lifetime risk of ovarian cancer is 16–68% and 11–30% in female BRCA1 and BRCA2 gene alteration carriers, respectively. Risk-reducing bilateral salpingo-oophorectomy (RRSO) is the only proven way to reduce ovarian cancer mortality. We report a series of patients who underwent risk-reducing surgery at the time of planned obstetric-indicated cesarean delivery. CASES: This is a case series of four women carrying a pathogenic germline BRCA1 or BRCA2 gene alteration who underwent RRSO at the time of cesarean delivery between March 1, 2018, and March 31, 2022. All women were referred during pregnancy to the University College London Hospitals Familial Cancer Clinic for consideration of RRSO at the time of obstetric-indicated cesarean delivery. Women were considered eligible for RRSO if they had a proven pathogenic germline alteration, would have completed childbearing after the cesarean delivery, and were older than age 35 or 40 years with BRCA1 or BRCA2 alterations, respectively. Operating time, blood loss, transfusion requirements, length of hospital stay, complications, and ability to breastfeed were assessed and, where possible, compared with the institutional means for similar patients who underwent cesarean delivery only, to determine whether RRSO was associated with increased morbidity. Women were contacted 11–59 months postprocedure to assess satisfaction. The mean blood loss was 687 mL (range 400–1,000 mL), mean operating time was 68 minutes, mean length of hospital stay was 3 days, and mean change in hemoglobin was −1 g/dL. No patient required a transfusion, had internal organ damage, returned to the operating room, or was readmitted. One of two women with intact breast tissue successfully breastfed, and the other chose to bottle feed. The mean contemporaneous institutional blood loss for cesarean delivery was not significantly different at 681 mL for singleton pregnancies and 872 mL for twin pregnancies. All four women reported a high level of satisfaction with the combined procedure. CONCLUSION: Our results show that RRSO can be performed at the time of cesarean delivery with high patient satisfaction. This approach can be offered to appropriately counseled individuals, with the benefit of avoiding the need for two separate procedures, with potentially reduced patient morbidity and health care costs. Lippincott Williams & Wilkins 2023-12 2023-11-02 /pmc/articles/PMC10642698/ /pubmed/37917945 http://dx.doi.org/10.1097/AOG.0000000000005423 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cases and Practice
Barker, Victoria E.
Vlachodimitropoulou, Evangelia
O’Brien, Patrick
Iskaros, Joseph
Rosenthal, Adam N.
Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers: A Case Series
title Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers: A Case Series
title_full Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers: A Case Series
title_fullStr Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers: A Case Series
title_full_unstemmed Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers: A Case Series
title_short Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers: A Case Series
title_sort combined bilateral salpingo-oophorectomy and cesarean delivery in brca1/2 alteration carriers: a case series
topic Clinical Cases and Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642698/
https://www.ncbi.nlm.nih.gov/pubmed/37917945
http://dx.doi.org/10.1097/AOG.0000000000005423
work_keys_str_mv AT barkervictoriae combinedbilateralsalpingooophorectomyandcesareandeliveryinbrca12alterationcarriersacaseseries
AT vlachodimitropoulouevangelia combinedbilateralsalpingooophorectomyandcesareandeliveryinbrca12alterationcarriersacaseseries
AT obrienpatrick combinedbilateralsalpingooophorectomyandcesareandeliveryinbrca12alterationcarriersacaseseries
AT iskarosjoseph combinedbilateralsalpingooophorectomyandcesareandeliveryinbrca12alterationcarriersacaseseries
AT rosenthaladamn combinedbilateralsalpingooophorectomyandcesareandeliveryinbrca12alterationcarriersacaseseries